Oxidative stress induced by high salt diet—possible implications for development and clinical manifestation of cutaneous inflammation and endothelial dysfunction in …
Although oxidative stress is recognized as an important effector mechanism of the immune
system, uncontrolled formation of reactive oxygen and nitrogen species promotes excessive …
system, uncontrolled formation of reactive oxygen and nitrogen species promotes excessive …
Biologics for reducing cardiovascular risk in psoriasis patients
H Terui, Y Asano - Journal of Clinical Medicine, 2023 - mdpi.com
Psoriasis is a chronic inflammatory skin disease with a high prevalence of cardiovascular
disease (CVD), obesity, dyslipidemia, hypertension, diabetes mellitus, and metabolic …
disease (CVD), obesity, dyslipidemia, hypertension, diabetes mellitus, and metabolic …
Effect of secukinumab on traditional cardiovascular risk factors and inflammatory biomarkers: Post hoc analyses of pooled data across three indications
Abstract Background Psoriasis, psoriatic arthritis (PsA), and axial spondyloarthritis (axSpA)
are chronic immune-mediated inflammatory diseases (IMIDs) associated with cardiovascular …
are chronic immune-mediated inflammatory diseases (IMIDs) associated with cardiovascular …
Does systemic anti-psoriatic treatment impact the risk of cardiovascular disease? A review over cardiovascular imaging studies
H Kaiser, C Näslund-Koch, A Kvist-Hansen… - Dermatology and …, 2024 - Springer
Psoriasis is an immune-mediated inflammatory disease associated with an increased risk of
cardiovascular disease (CVD). The risk of CVD increases with the severity of psoriasis, and …
cardiovascular disease (CVD). The risk of CVD increases with the severity of psoriasis, and …
The impact of treatment with IL-17/IL-23 inhibitors on subclinical atherosclerosis in patients with plaque psoriasis and/or psoriatic arthritis: a systematic review
Accumulating evidence considers psoriasis a systemic inflammatory disorder that is
associated with comorbidities such as psoriatic arthritis, cardiovascular disease, and …
associated with comorbidities such as psoriatic arthritis, cardiovascular disease, and …
Exploration of ferroptosis and necroptosis-related genes and potential molecular mechanisms in psoriasis and atherosclerosis
J Fan, T Zhu, X Tian, S Liu, SL Zhang - Frontiers in Immunology, 2024 - frontiersin.org
Objective Ferroptosis and necroptosis are two recently identified forms of non-apoptotic cell
death. Their dysregulation plays a critical role in the development and progression of …
death. Their dysregulation plays a critical role in the development and progression of …
Reducing cardiovascular risk in immune‐mediated inflammatory diseases: Tumour necrosis factor inhibitors compared to conventional therapies—A systematic review …
NÁ Galajda, FA Meznerics, P Mátrai… - Journal of the …, 2024 - Wiley Online Library
Immune‐mediated inflammatory disease (IMID) patients including psoriasis, inflammatory
arthritides and bowel diseases have a higher risk of developing cardiovascular (CV) …
arthritides and bowel diseases have a higher risk of developing cardiovascular (CV) …
Interleukin-17–targeted treatment in patients with spondyloarthritis and associated cardiometabolic risk profile
R Queiro, E Aurrecoechea, S Alonso Castro… - Frontiers in …, 2023 - frontiersin.org
Spondyloarthritis is a group of immune-mediated rheumatic disorders that significantly
impact patients' physical function and quality of life. Patients with spondyloarthritis …
impact patients' physical function and quality of life. Patients with spondyloarthritis …
Biological, as opposed to classic antipsoriatic drug or apremilast, treatment mitigates the risk of death and cardiovascular disease in psoriasis
Background Cardiovascular comorbidity increases morbidity and mortality in psoriasis.
Systemic treatments, particularly biologics, are effective in alleviating skin and joint …
Systemic treatments, particularly biologics, are effective in alleviating skin and joint …
Circulating interleukin 17A and other inflammatory proteins may predict cardiovascular disease in early rheumatoid arthritis
E Rydell, LTH Jacobsson, C Turesson - The Journal of Rheumatology, 2024 - jrheum.org
Objective The objective of this study was to investigate the impact of 92 inflammatory
proteins on the risk of cardiovascular disease (CVD) in patients with early rheumatoid …
proteins on the risk of cardiovascular disease (CVD) in patients with early rheumatoid …